HomeProductsBioactive CompoundsNeuronal Signaling5-HT ReceptorVelusetrag
Chemical structure of CAS 866933-46-2

Velusetrag

In Stock•Starting at $468 for 1 mg•Purity ≥ 99%
CAS No.866933-46-2
MDL No.N/A
MFC25H36N4O5S
MW504.60
InChI KeyHXLOHDZQBKCUCR-VTHDOGFWSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99%$468In Stock
5 mg99%$1018In Stock
10 mg99%$1679In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.866933-46-2
Product NameVelusetrag

Biological Targets

HTR4

Associated Conditions

intestinal pseudo-obstruction·gastroparesis·Alzheimer disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Phase II drugs under clinical investigation for the treatment of chronic constipation.

Expert opinion on investigational drugs • Vol. 23, Issue 11 • 2014
PMID: 24960333DOI: 10.1517/13543784.2014.932770

Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.

Bioorganic & medicinal chemistry letters • Vol. 22, Issue 19 • 2012
PMID: 22959244DOI: 10.1016/j.bmcl.2012.08.051

New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.

Expert opinion on investigational drugs • Vol. 19, Issue 6 • 2010
PMID: 20408739DOI: 10.1517/13543784.2010.482927

The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.

Naunyn-Schmiedeberg's archives of pharmacology • Vol. 378, Issue 1 • 2008
PMID: 18415081DOI: 10.1007/s00210-008-0282-y

Documentation

Similar Products